Trial Profile
A retrospective study of bevacizumab verses bevacizumab/lomustine in patients with recurrent glioblastoma multiforme
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Lomustine (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 28 Nov 2016 New trial record